Safeguard Scientifics Inc (SFES)
Company Description
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings.
It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector.
Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million.
Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services.
It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada.
The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing.
It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner.
The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent.
However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property.
The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Sa
Country | United States |
Founded | 1953 |
Industry | Asset Management |
Sector | Financials |
CEO | Robert Rosenthal |
Contact Details
Address: 150 North Radnor-chester Road, Suite F-200 Radnor, Pennsylvania 19087 United States | |
Phone | 610 293 0600 |
Stock Details
Ticker Symbol | SFES |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000086115 |
Employer ID | 23-1609753 |
SIC Code | 6799 |
Key Executives
Name | Position |
---|---|
Mark Dow | Chief Executive Officer, Chief Financial Officer and Company Secretary |
G. Matthew Barnard | General Counsel, Secretary and Compliance Officer |
Alex A. Fuiks | Associate |
Seth Zuckerman | Senior Associate of Healthcare |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 26, 2024 | 10-K | Annual Report |
Feb 20, 2024 | 15-12G | Securities registration termination |
Feb 20, 2024 | SC 13E3/A | [Amend] Going private transaction by certain issuers |
Feb 16, 2024 | EFFECT | Notice of Effectiveness |
Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Feb 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Feb 12, 2024 | 8-K | Current Report |
Feb 9, 2024 | POS AM | Post-Effective amendments for registration statement |
Feb 9, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |